|
Note: If you are a patient of Dr. Auer's, or if you would like a referral, please go to www.mydoctor.ca/drauer.
Associate Scientist, Cancer Therapeutics, Ottawa Hospital Research Institute
Surgical Oncologist, The Ottawa Hospital Cancer Centre
Assistant Professor, Department of Surgery, University of Ottawa
Research
Dr. Rebecca Auer (formerly Taylor) is a Surgical Oncologist and Associate Scientist working closely with Dr. John Bell and Dr. Harry Atkins in the OHRI Cancer Therapeutics Program. Her medical specialty is colorectal and hepatobiliary surgery and her research focuses on the use of oncolytic viruses as novel cancer therapeutics. She is particularly interested in translational research - studying the effects of oncolytic viruses in cancer patients and developing tests to predict which patients will respond. In addition, she is interested in studying the interaction of the immune system with the virus and the tumor as one mechanism of clinical efficacy. Dr. Auer joined the OHRI in September 2007 after completing a fellowship at the Memorial Sloan-Kettering Cancer Center in New York. Before that, she completed her medical residency and an MSc in Human and Molecular Genetics at the University of Ottawa.
Selected Publications
Taylor RC, R. R. White, N. Kemeny, W. Jarnagin, R. P. Dematteo, Y. Fong, L. H. Blumgart, M. D'Angelica. Predictors of a true complete response among disappearing lesions following chemotherapy for colorectal liver metastases. (Presented at the American Society of Clinical Oncology, June 2007)
Taylor RC, Turoto S, White R, Akhurst T, Fong Y. Evaluation with Positron Emission Tomography before hepatic resection of metastatic colorectal cancer improves survival in patients with a high Clinical Risk Score. (Presented at the GI American Society of Clinical Oncology, January 2007 and Society of Surgical Oncology, March 2007)
Taylor RC, Patel A, Busam K, Brady MS. Tumor infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol, Nov 2006;25(7):869-75.
Lichty B, Stojdl D, Taylor R. Miller L, Frenkel I, Atkins H, Bell J. Vesicular Stomatitis Virus: A potential therapeutic virus for the treatment of hematological malignancies. Hum Gene Therapy. 2004;15(9):821-831.
Taylor RC. Regulation of Vesicular Stomatitis Virus infection in resting and activated T lymphocytes (Masters Thesis), University of Ottawa Press, 2004.
Taylor R, Taguchi K. Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump. Ann Fam Med. 2005;3(3):242-247.
Taylor RC, Fong Y. Surgical Treatment of Hepatic Metastasis from Colorectal Cancer. In Surgery of the Liver, Biliary Tract and Pancreas 4th Edition. Blumgart (ed), Saunders Elsevier, 2006.
Taylor RC, Tomlinson J, Kemeny N. Regional Chemotherapy of Primary and Metastatic Liver Tumors, In Regional Chemotherapy, Schlag (ed), Humana Press, 2007.
Taylor R, Paterson J, Bell J. Vesicular Stomatitis is an oncolytic virus that exploits tumour specific defects in the interferon pathway. In Viral Therapy for Human Cancers. Marcel Deller Publishing, 2004.
Note: This is not a complete list of publications. More publications may be available in The Ottawa Hospital Library database and Pubmed (search by last name and initials).
| |
General Campus
(see 
